deltatrials
Recruiting OBSERVATIONAL NCT03144648

PRECAMA: Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women (PRECAMA)

Molecular Subtypes of Premenopausal Breast Cancer in Latin American Women (PRECAMA): a Multicenter Population-based Case-control Study

Sponsor: Barretos Cancer Hospital

Conditions Breast Cancer Female
Interventions lifestyle
Updated 17 times since 2017 Last updated: May 1, 2025 Started: Oct 12, 2012 Primary completion: Dec 30, 2025 Completion: Dec 30, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Breast Cancer Female and is currently actively recruiting participants. Barretos Cancer Hospital leads this study, which shows 17 recorded versions since 2012 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jul 2017 – ~Aug 2017 · 31 days · monthly snapshot~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Mar 2020 · 22 months · monthly snapshot~Mar 2020 – ~Nov 2020 · 8 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~May 2022 · 5 months · monthly snapshot~May 2022 – ~Sep 2023 · 16 months · monthly snapshot~Sep 2023 – ~Nov 2023 · 2 months · monthly snapshot~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshot~Jun 2025 – ~Sep 2025 · 3 months · monthly snapshot~Sep 2025 – ~Nov 2025 · 2 months · monthly snapshot~Nov 2025 – present · 8 months · monthly snapshot

Change History

17 versions recorded

  1. Nov 2025 — Present [monthly]

    Recruiting

  2. Sep 2025 — Nov 2025 [monthly]

    Recruiting

  3. Jun 2025 — Sep 2025 [monthly]

    Recruiting

  4. Sep 2024 — Jun 2025 [monthly]

    Recruiting

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting

▶ Show 12 earlier versions

  1. Nov 2023 — Jul 2024 [monthly]

    Recruiting

    Status: Unknown Status → Recruiting

  2. Sep 2023 — Nov 2023 [monthly]

    Unknown Status

    Status: Recruiting → Unknown Status

  3. May 2022 — Sep 2023 [monthly]

    Recruiting

  4. Dec 2021 — May 2022 [monthly]

    Recruiting

  5. Sep 2021 — Dec 2021 [monthly]

    Recruiting

  6. Jan 2021 — Sep 2021 [monthly]

    Recruiting

  7. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  8. Mar 2020 — Nov 2020 [monthly]

    Recruiting

  9. May 2018 — Mar 2020 [monthly]

    Recruiting

  10. Apr 2018 — May 2018 [monthly]

    Recruiting

    Phase: NA → None

  11. Aug 2017 — Apr 2018 [monthly]

    Recruiting NA

  12. Jul 2017 — Aug 2017 [monthly]

    Recruiting NA

    First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Barretos Cancer Hospital
  • Fundación Inciensa
  • Instituto Nacional de Salud Publica, Mexico
  • International Agency for Research on Cancer
  • Universidad de Antioquia
  • University of Chile
Data source: International Agency for Research on Cancer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations